Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Djupt parasternalt interkostalt planblock minskar opioidkonsumtion efter sternotomi

10 november 2026 uppdaterad av: Burak Cemil Balık, Gaziantep City Hospital

Preoperative Ultrasound-Guided Deep Parasternal Intercostal Plane Block and Intraoperative Opioid Consumption in Adults Undergoing Cardiac Surgery Via Median Sternotomy

Median sternotomy is commonly used in cardiac surgery and is associated with significant intraoperative and postoperative pain, often requiring substantial opioid administration. High opioid use during cardiac surgery may contribute to adverse effects such as respiratory depression, delayed extubation, postoperative nausea and vomiting, and prolonged intensive care unit stay. Therefore, effective opioid-sparing strategies are an important component of modern perioperative care.

The deep parasternal intercostal plane (DPIP) block is a regional anesthesia technique that targets the anterior cutaneous branches of the intercostal nerves, which are responsible for transmitting pain from the sternum and adjacent tissues. When performed under ultrasound guidance, this block allows precise local anesthetic deposition while minimizing the risk of pleural or vascular injury.

The purpose of this randomized controlled study is to evaluate whether a preoperative ultrasound-guided DPIP block reduces intraoperative opioid consumption in adult patients undergoing elective cardiac surgery via median sternotomy. Patients will be randomly assigned to receive either a bilateral DPIP block in addition to standard general anesthesia or standard general anesthesia alone.

The primary outcome of the study is total intraoperative opioid consumption. Secondary outcomes include time to extubation, postoperative opioid consumption within the first 24 hours, postoperative pain scores, and the incidence of opioid-related adverse effects. The results of this study may help define the role of the DPIP block as part of a multimodal, opioid-sparing analgesic strategy in cardiac surgery.

Studieöversikt

Detaljerad beskrivning

Adequate pain control during and after cardiac surgery via median sternotomy remains challenging despite advances in perioperative care. Opioids continue to be the mainstay of analgesia; however, excessive intraoperative opioid administration has been associated with delayed extubation, respiratory complications, postoperative nausea and vomiting, and prolonged intensive care unit stay. As part of enhanced recovery protocols, regional anesthesia techniques that provide effective opioid-sparing analgesia are increasingly emphasized.

The deep parasternal intercostal plane (DPIP) block is a relatively novel ultrasound-guided regional anesthesia technique that targets the anterior cutaneous branches of the intercostal nerves within the fascial plane between the internal intercostal and transversus thoracis muscles. Compared with more proximal neuraxial or paravertebral techniques, the DPIP block offers a more localized and anatomically specific approach to sternotomy-related pain while potentially reducing the risk of serious complications.

In this prospective, randomized controlled trial, adult patients scheduled for elective cardiac surgery via median sternotomy will be allocated to one of two parallel groups. Patients in the intervention group will receive a bilateral ultrasound-guided DPIP block performed preoperatively after induction of general anesthesia, in addition to standardized general anesthesia management. Patients in the control group will receive standardized general anesthesia alone, without a regional block. Perioperative anesthetic management, including opioid administration, will follow institutional protocols and will be guided by routine clinical parameters.

The primary objective of the study is to assess the effect of the preoperative DPIP block on total intraoperative opioid consumption. Secondary objectives include evaluation of early recovery parameters such as time to extubation, postoperative opioid requirements within the first 24 hours, postoperative pain intensity, and the occurrence of opioid-related adverse events. Safety outcomes related to the block procedure will also be recorded.

This study is designed to provide clinically relevant data on the role of the DPIP block as part of a multimodal analgesic strategy in cardiac surgery. By focusing on intraoperative opioid consumption and early recovery outcomes, the trial aims to clarify whether preoperative application of this targeted regional technique can contribute to improved perioperative management and opioid-sparing anesthesia in patients undergoing median sternotomy.

Studietyp

Interventionell

Inskrivning (Faktisk)

81

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

    • Sahinbey
      • Gaziantep, Sahinbey, Turkiet (Türkiye)
        • Gaziantep Sehir Hastanesi

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

18 år till 65 år (Vuxen, Äldre vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

Adults aged 18 to 65 years Scheduled to undergo elective cardiac surgery via median sternotomy Planned general anesthesia Able to provide written informed consent Sufficient cognitive capacity to participate in postoperative clinical assessments.

Exclusion Criteria:

Emergency cardiac surgery. Cardiac surgery performed through an approach other than median sternotomy. Redo sternotomy. Known allergy or hypersensitivity to amide local anesthetics. Clinically significant coagulopathy or antithrombotic treatment contraindicating regional anesthesia according to the institutional protocol.

Infection or impaired skin integrity at or near the planned block site. Unstable clinical conditions considered to increase the risk of pleural complications.

Chronic opioid use. Pre-existing chronic pain syndromes. Major musculoskeletal deformity affecting pain assessment. Neurological or psychiatric disorders preventing valid postoperative assessment.

Clinically significant peripheral neuropathy. Severe pulmonary disease. Pregnancy or lactation. Severe cognitive impairment or inability to communicate pain intensity. Refusal or inability to provide written informed consent. Inability to comply with the study protocol.

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Stödjande vård
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Dubbel

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Deep Parasternal Intercostal Plane Block Group

Participants receive bilateral ultrasound-guided deep parasternal intercostal plane (DPIP) block after induction of general anesthesia and before median sternotomy, in addition to standardized general anesthesia and protocolized intraoperative opioid management. Remifentanil is titrated according to predefined clinical and hemodynamic criteria, with rescue fentanyl administered when indicated.

Bilateral ultrasound-guided deep parasternal intercostal plane block is performed after induction of general anesthesia and before median sternotomy. Bupivacaine 0.25% is injected into the fascial plane between the internal intercostal and transversus thoracis muscles, using 10 mL (25 mg) per side, for a total volume of 20 mL and a total dose of 50 mg.

Standardized general anesthesia is administered according to the institutional cardiac anesthesia protocol. Intraoperative remifentanil infusion is initiated at 0.05 µg/kg/min and titrated according to predefined clinical and hemodynamic criteria, with a maximum infusion rate of 0.2 µg/kg/min. Rescue fentanyl (0.5 µg/kg intravenously) is administered when clinically indicated according to the protocol. The same opioid titration criteria are applied in both study groups; actual opioid doses vary according to individual patient requirements.

Aktiv komparator: Standard Analgesia (Control) Group

Participants receive standardized general anesthesia and the same protocolized intraoperative opioid management as the DPIP group, without any regional anesthesia technique. Remifentanil is titrated according to the same predefined clinical and hemodynamic criteria, with rescue fentanyl administered when indicated.

Standardized general anesthesia is administered according to the institutional cardiac anesthesia protocol. Intraoperative remifentanil infusion is initiated at 0.05 µg/kg/min and titrated according to predefined clinical and hemodynamic criteria, with a maximum infusion rate of 0.2 µg/kg/min. Rescue fentanyl (0.5 µg/kg intravenously) is administered when clinically indicated according to the protocol. The same opioid titration criteria are applied in both study groups; actual opioid doses vary according to individual patient requirements.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Total Intraoperative Opioid Consumption
Tidsram: From induction of general anesthesia until completion of surgery

Total intraoperative opioid consumption recorded from anesthesia records. In the remifentanil-based protocol, opioid consumption will be assessed primarily as total remifentanil dose, duration-normalized remifentanil consumption, and weight- and duration-normalized remifentanil consumption. Rescue fentanyl use will be recorded separately.

From induction of general anesthesia until completion of surgery

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Intraoperative Hemodynamic Stability
Tidsram: During surgery

Incidence of intraoperative hemodynamic instability, defined as the need for additional opioid administration or vasoactive support in response to surgical stimulation, recorded from anesthesia records.

During surgery
Time to Extubation
Tidsram: From completion of surgery to successful tracheal extubation in the intensive care unit

Time elapsed between the end of surgery and successful tracheal extubation, recorded in minutes.

From completion of surgery to successful tracheal extubation in the intensive care unit
Postoperative Opioid Consumption
Tidsram: First 24 hours postoperatively

Cumulative amount of opioids administered during the first 24 postoperative hours, expressed as intravenous morphine equivalents (mg), obtained from medical records.

First 24 hours postoperatively
Time to First Rescue Analgesia
Tidsram: Up to 24 hours postoperatively

Time elapsed from arrival in the intensive care unit to the administration of the first rescue analgesic medication.

Up to 24 hours postoperatively
Block-Related Complications
Tidsram: Intraoperative period and first 24 postoperative hours

Incidence of complications related to the parasternal intercostal plane block, including but not limited to pneumothorax, vascular puncture, local anesthetic systemic toxicity, and infection.

Intraoperative period and first 24 postoperative hours

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Publikationer och användbara länkar

Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

12 februari 2026

Primärt slutförande (Faktisk)

7 juni 2026

Avslutad studie (Faktisk)

8 juni 2026

Studieregistreringsdatum

Först inskickad

18 december 2025

Först inskickad som uppfyllde QC-kriterierna

18 december 2025

Första postat (Faktisk)

2 januari 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

16 november 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

10 november 2026

Senast verifierad

1 juni 2026

Mer information

Termer relaterade till denna studie

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

IPD-planbeskrivning

Individual participant data will not be shared, as the study is a single-center clinical trial and data sharing was not included in the original study protocol or approved by the institutional ethics committee. De-identified aggregate data will be reported in scientific publications.

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera